AUSTIN, Texas , May 7, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2025. Please click the included PDF link to access the full earnings press release.

- End-of-Phase 2 meeting with FDA requested for Alzheimer's disease - - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC - - Two posters at ARVO describe zervimesine's role supporting retinal cell health - PURCHASE, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2025, and provided a business update.

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced it will webcast its 2025 Investor Day beginning at 9:00 a.m. ET on Wednesday, May 21, 2025. The event should conclude at approximately 12:00 p.m. ET. Presentations by Russell A. Becker, President and Chief Executive Officer; David Jackola, Executive Vice President and Chief Financial Officer; and members of APi's senior leadership team will highlight new, meaningfully higher long-ter.

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming investor events: BofA Securities 2025 Health Care Conference – May 13-15, 2025 Type: Fireside Chat Presentation Date/Time: May 14, 2025, 11:20 a.m. PDT 2025 RBC Capital Markets Global Healthcare – May 20-21, 2025 Type: Fireside Chat Presentation Date/Time: May 20, 2025, 2:35 p.m. EDT Presentation webcasts may be accessed on the Events an.

CrowdStrike will cut hundreds of jobs, as artificial intelligence reshapes the cybersecurity business.

U.S. electric and gas utility NiSource beat Wall Street estimates for first-quarter profit on Wednesday, driven by strong demand for power.

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. As researchers uncover the pote.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ePlus inc. ("ePlus inc.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation ("Universal Display Corporation") (NASDAQ:OLED) concerning possible violations of federal securities laws. On October 30, 2024, Universal announced 3Q 2024 revenue results that fell short of consensus and lowered its CY2024 revenue guidance.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cerevel-therapeutics-holdings-inc-lawsuit-submission-form?prid=147234&wire=1 or contact Joseph E. Levi, Esq.

Revenue rose 15.8% year-over-year, down from 22.0% in Q4. EBITDA growth also decelerated, landing at 36.9% compared to 62.5% the previous quarter. In Q4, Total Reach Campaign usage was up 82%, but that surge hasn't been mirrored in top-line growth - a gap that continued into Q1. That suggests ad yield and efficiency aren't fully dialed in yet. The bull case strengthens if EBITDA margins continue climbing toward (or past) 10%, ARPU keeps growing in the double digits, and Roku begins closing the gap between TRC engagement and monetization.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=147233&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sana-biotechnology-inc-lawsuit-submission-form?prid=147232&wire=1 or contact Joseph E. Levi, Esq.

The measures are the first to be announced since President Donald Trump unveiled his sweeping tariffs in early April that put the levy on Chinese goods at more than 100%.

Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise, defying the 55% stock drop. Novo Nordisk's profitability and growth in emerging markets, coupled with a forward P/E ratio of 16.35x, make it an undervalued investment opportunity. Market concerns over minor market share losses are overblown; NVO remains the leader in a rapidly growing obesity and diabetes market.

Looking for broad exposure to the Small Cap Value segment of the US equity market? You should consider the Pacer US Small Cap Cash Cows ETF (CALF), a passively managed exchange traded fund launched on 06/16/2017.

The JPMorgan Diversified Return Emerging Markets Equity ETF (JPEM) was launched on 01/07/2015, and is a smart beta exchange traded fund designed to offer broad exposure to the Broad Emerging Market ETFs category of the market.

The Nuveen ESG Small-Cap ETF (NUSC) made its debut on 12/13/2016, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Small Cap Growth category of the market.

Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the Pacer US Cash Cows 100 ETF (COWZ) is a passively managed exchange traded fund launched on 12/16/2016.

Looking for broad exposure to the Financials - Broad segment of the equity market? You should consider the iShares MSCI Europe Financials ETF (EUFN), a passively managed exchange traded fund launched on 01/20/2010.